ReviewUrology annals

Survival rate comparisons of angioembolization and neoadjuvant targeted therapy on unresectable renal cell carcinoma patients: A systematic review.

Rifqi Yanda Muhammad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.